Global Endometriosis Market Size, Share & Industry Trends Analysis Report By Type, By Treatment (Oral Contraceptives, Gonadotropin-releasing hormone (GnRH) medicines, and Others), By Distribution Channel, By Regional Outlook and Forecast, 2022 - 2028

The Global Endometriosis Market size is expected to reach $2.2 billion by 2028, rising at a market growth of 11.6% CAGR during the forecast period.

Endometrial-like tissue that arises in unintended places is a typical symptom of endometriosis. The tissue that develops and sheds in the uterus is known as endometrial tissue. The majority of the time, this growth occurs on and around pelvic cavity organs. Similar to the tissue inside the uterus, endometrial tissue undergoes growth, thickening, and attempts at shedding with each menstrual cycle.

The tissue can result in adhesions, tumors, and lesions that set off an inflammatory reaction since it has no way to leave the body. This may result in discomfort and other issues, such as infertility. Over the years, various causes of endometriosis have been proposed. The endometrium is the name for the lining of the uterus. According to one notion, endometrial cells can go from the uterus to the pelvic region. When a patient has a period, they pour backward along the Fallopian tubes and end up there.

Endometriosis patches have a tendency to be "sticky" and can connect organs. Adhesions are the medical word for this. The gut or bladder, for instance, could "stuck" to the uterus. Large endometriosis patches might develop into cysts that bleed every month during menstruation. The cysts are referred to as "chocolate cysts" and might swell up with black blood.

Without a formal diagnosis, many endometriosis patients receive treatment based solely on their symptoms. In some instances, a laparoscopy, a straightforward surgery, is used to provide an authoritative diagnosis. In this operation, a tiny abdominal incision (often less than 1.5cm/0.6 inches) is made, through which a camera is inserted to view the pelvic cavity. Biopsies, or small tissue samples, can be taken.

COVID-19 Impact Analysis

The COVID-19 outbreak is projected to have a negative effect on the endometriosis market due to the massive restructuring of medical schools and hospitals around the world to expand hospital capacity for COVID-19 patients. During the pandemic, the development and discovery of endometriosis treatments slowed but did not stop. Healthcare providers were only accepting emergency cases and suggested home care more to the less important cases. Moreover, the shutdown of production facilities and the lack of raw materials like gelatin significantly interrupted the supply chain for endometriosis medications.

Market Growth Factors

Government efforts to raise endometriosis awareness

Establishing referral networks and care pathways with advanced imaging, pharmaceutical, surgical, fertility, and multidisciplinary interventions at tertiary and secondary centers with good connections to primary healthcare facilities. Increasing the availability of tools (such as ultrasound or magnetic resonance imaging) and medications will help health systems be better equipped to detect and treat endometriosis early (e.g., combined oral contraceptives, non-steroidal analgesics, and progestin-based contraceptives). The market growth will be boosted by numerous significant governmental entities conducting programs and other awareness programs to raise awareness. This would increasingly support the market growth during the projection period.

Increasing incidence of gynecological disorders such as endometriosis

Endometriosis is a condition in which tissue that resembles the uterine lining grows outside of the uterus, resulting in pain and/or infertility. Around 10% (190 million) of women and adolescents of reproductive age suffer from endometriosis worldwide. It is a chronic condition that causes excruciating, life-altering agony during periods, sexual activity, bowel and/or bladder movements, chronic pelvic discomfort, stomach bloating, nausea, exhaustion, and occasionally depression, anxiety, and infertility.

Market Restraining Factor

The absence of non-invasive endometriosis diagnostic tests

A diagnostic test's usefulness and validity are primarily determined by its sensitivity and specificity for a certain ailment. However, it can occasionally be challenging to comprehend and apply these measures to clinical decision-making. The likelihood that a positive or negative test would properly identify whether a patient has the condition is known as the positive predictive value (PPV) or negative predictive value (NPV). The endometriosis market is predicted to experience slow expansion due to the absence of appropriate and efficient diagnosis devices.

Type Outlook

Based on type, the endometriosis market is segmented into superficial peritoneal lesion, endometriomas and others. The superficial peritoneal lesion segment generated the highest revenue share in the endometriosis market in 2021. This is a result of the increase in the incidence of superficial peritoneal lesions and the creation of programs to raise endometriosis awareness. Additionally, a rise in government financing for endometriosis research has accelerated the development of the superficial peritoneal lesion segment.

Distribution Channel Outlook

On the basis of distribution channel, the endometriosis market is categorized into hospital pharmacy, online pharmacy, and retail pharmacy. The hospital pharmacy segment witnessed the largest revenue share in the endometriosis market in 2021. This is due to an expansion in hospital pharmacies and a rise in patients' confidence in hospitals as providers of high-quality care. The hospital pharmacy market is primarily driven by the growing trend of endometriosis therapy as an alternative to surgery. Hospital pharmacists can also help endometriosis patients, and their carers choose the right medications because they are knowledgeable about medications. Such elements all encourage sector expansion.

Treatment Outlook

By treatment, the endometriosis market is bifurcated into oral contraceptives, gonadotropin-releasing hormone (GnRH) medicines and others. The gonadotropin-releasing hormone (GnRH) medicines segment recorded a prominent revenue share in the endometriosis market in 2021. They are available as a tablet, injection, shot, or nasal spray. Orilissa (elagolix), manufactured by AbbVie Inc., was the first drug given FDA approval to alleviate disease-related pain. Patients who are resistant to the first line of treatment should consider GnRH agonists and antagonists as alternatives.

Endometriosis Market Report Coverage

Report Attribute	Details
Market size value in 2021	USD 1 Billion
Market size forecast in 2028	USD 2.2 Billion
Base Year	2021
Historical Period	2018 to 2020
Forecast Period	2022 to 2028
Revenue Growth Rate	CAGR of 11.6% from 2022 to 2028
Number of Pages	204
Number of Tables	350
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling
Segments covered	Treatment, Type, Distribution Channel, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Government efforts to raise endometriosis awareness Increasing incidence of gynecological disorders such as endometriosis
Restraints	The absence of non-invasive endometriosis diagnostic tests

Regional Outlook

Region wise, the endometriosis market is analyzed across North America, Europe, Asia Pacific and LAMEA. The North America region dominated the endometriosis market with maximum revenue share in 2021. This is mostly linked to an increase in endometriosis cases, which necessitate additional treatments such as gonadotropin-releasing hormone (GnRH) medications, an increase in government financing for endometriosis research, and a considerable increase in capital income in developed countries. The sophisticated reimbursement structures that exist and are designed to lower expenditure levels also contribute to the market's expansion.

Free Valuable Insights: Global Endometriosis Market size to reach USD 2.2 Billion by 2028

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., Sanofi S.A., AbbVie, Inc., AstraZeneca PLC, Pfizer, Inc., Merck & Co., Inc., GlaxoSmithKline PLC, Abbott Laboratories, and Consilient Health Limited.

Scope of the Study

Market Segments Covered in the Report:

By Type

• Superficial Peritoneal Lesion
• Endometriomas
• Others

By Treatment

• Oral Contraceptives
• Gonadotropin-releasing hormone (GnRH) medicines
• Others

By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Teva Pharmaceuticals Industries Ltd.
• Sun Pharmaceutical Industries Ltd.
• Sanofi S.A.
• AbbVie, Inc.
• AstraZeneca PLC
• Pfizer, Inc.
• Merck & Co., Inc.
• GlaxoSmithKline PLC
• Abbott Laboratories
• Consilient Health Limited

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Endometriosis Market, by Type
1.4.2 Global Endometriosis Market, by Treatment
1.4.3 Global Endometriosis Market, by Distribution Channel
1.4.4 Global Endometriosis Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global Endometriosis Market by Type
3.1 Global Superficial Peritoneal Lesion Market by Region
3.2 Global Endometriomas Market by Region
3.3 Global Others Market by Region

Chapter 4. Global Endometriosis Market by Treatment
4.1 Global Oral Contraceptives Market by Region
4.2 Global Gonadotropin-releasing hormone (GnRH) medicines Market by Region
4.3 Global Others Market by Region

Chapter 5. Global Endometriosis Market by Distribution Channel
5.1 Global Hospital Pharmacy Market by Region
5.2 Global Retail Pharmacy Market by Region
5.3 Global Online Pharmacy Market by Region

Chapter 6. Global Endometriosis Market by Region
6.1 North America Endometriosis Market
6.1.1 North America Endometriosis Market by Type
6.1.1.1 North America Superficial Peritoneal Lesion Market by Country
6.1.1.2 North America Endometriomas Market by Country
6.1.1.3 North America Others Market by Country
6.1.2 North America Endometriosis Market by Treatment
6.1.2.1 North America Oral Contraceptives Market by Country
6.1.2.2 North America Gonadotropin-releasing hormone (GnRH) medicines Market by Country
6.1.2.3 North America Others Market by Country
6.1.3 North America Endometriosis Market by Distribution Channel
6.1.3.1 North America Hospital Pharmacy Market by Country
6.1.3.2 North America Retail Pharmacy Market by Country
6.1.3.3 North America Online Pharmacy Market by Country
6.1.4 North America Endometriosis Market by Country
6.1.4.1 US Endometriosis Market
6.1.4.1.1 US Endometriosis Market by Type
6.1.4.1.2 US Endometriosis Market by Treatment
6.1.4.1.3 US Endometriosis Market by Distribution Channel
6.1.4.2 Canada Endometriosis Market
6.1.4.2.1 Canada Endometriosis Market by Type
6.1.4.2.2 Canada Endometriosis Market by Treatment
6.1.4.2.3 Canada Endometriosis Market by Distribution Channel
6.1.4.3 Mexico Endometriosis Market
6.1.4.3.1 Mexico Endometriosis Market by Type
6.1.4.3.2 Mexico Endometriosis Market by Treatment
6.1.4.3.3 Mexico Endometriosis Market by Distribution Channel
6.1.4.4 Rest of North America Endometriosis Market
6.1.4.4.1 Rest of North America Endometriosis Market by Type
6.1.4.4.2 Rest of North America Endometriosis Market by Treatment
6.1.4.4.3 Rest of North America Endometriosis Market by Distribution Channel
6.2 Europe Endometriosis Market
6.2.1 Europe Endometriosis Market by Type
6.2.1.1 Europe Superficial Peritoneal Lesion Market by Country
6.2.1.2 Europe Endometriomas Market by Country
6.2.1.3 Europe Others Market by Country
6.2.2 Europe Endometriosis Market by Treatment
6.2.2.1 Europe Oral Contraceptives Market by Country
6.2.2.2 Europe Gonadotropin-releasing hormone (GnRH) medicines Market by Country
6.2.2.3 Europe Others Market by Country
6.2.3 Europe Endometriosis Market by Distribution Channel
6.2.3.1 Europe Hospital Pharmacy Market by Country
6.2.3.2 Europe Retail Pharmacy Market by Country
6.2.3.3 Europe Online Pharmacy Market by Country
6.2.4 Europe Endometriosis Market by Country
6.2.4.1 Germany Endometriosis Market
6.2.4.1.1 Germany Endometriosis Market by Type
6.2.4.1.2 Germany Endometriosis Market by Treatment
6.2.4.1.3 Germany Endometriosis Market by Distribution Channel
6.2.4.2 UK Endometriosis Market
6.2.4.2.1 UK Endometriosis Market by Type
6.2.4.2.2 UK Endometriosis Market by Treatment
6.2.4.2.3 UK Endometriosis Market by Distribution Channel
6.2.4.3 France Endometriosis Market
6.2.4.3.1 France Endometriosis Market by Type
6.2.4.3.2 France Endometriosis Market by Treatment
6.2.4.3.3 France Endometriosis Market by Distribution Channel
6.2.4.4 Russia Endometriosis Market
6.2.4.4.1 Russia Endometriosis Market by Type
6.2.4.4.2 Russia Endometriosis Market by Treatment
6.2.4.4.3 Russia Endometriosis Market by Distribution Channel
6.2.4.5 Spain Endometriosis Market
6.2.4.5.1 Spain Endometriosis Market by Type
6.2.4.5.2 Spain Endometriosis Market by Treatment
6.2.4.5.3 Spain Endometriosis Market by Distribution Channel
6.2.4.6 Italy Endometriosis Market
6.2.4.6.1 Italy Endometriosis Market by Type
6.2.4.6.2 Italy Endometriosis Market by Treatment
6.2.4.6.3 Italy Endometriosis Market by Distribution Channel
6.2.4.7 Rest of Europe Endometriosis Market
6.2.4.7.1 Rest of Europe Endometriosis Market by Type
6.2.4.7.2 Rest of Europe Endometriosis Market by Treatment
6.2.4.7.3 Rest of Europe Endometriosis Market by Distribution Channel
6.3 Asia Pacific Endometriosis Market
6.3.1 Asia Pacific Endometriosis Market by Type
6.3.1.1 Asia Pacific Superficial Peritoneal Lesion Market by Country
6.3.1.2 Asia Pacific Endometriomas Market by Country
6.3.1.3 Asia Pacific Others Market by Country
6.3.2 Asia Pacific Endometriosis Market by Treatment
6.3.2.1 Asia Pacific Oral Contraceptives Market by Country
6.3.2.2 Asia Pacific Gonadotropin-releasing hormone (GnRH) medicines Market by Country
6.3.2.3 Asia Pacific Others Market by Country
6.3.3 Asia Pacific Endometriosis Market by Distribution Channel
6.3.3.1 Asia Pacific Hospital Pharmacy Market by Country
6.3.3.2 Asia Pacific Retail Pharmacy Market by Country
6.3.3.3 Asia Pacific Online Pharmacy Market by Country
6.3.4 Asia Pacific Endometriosis Market by Country
6.3.4.1 China Endometriosis Market
6.3.4.1.1 China Endometriosis Market by Type
6.3.4.1.2 China Endometriosis Market by Treatment
6.3.4.1.3 China Endometriosis Market by Distribution Channel
6.3.4.2 Japan Endometriosis Market
6.3.4.2.1 Japan Endometriosis Market by Type
6.3.4.2.2 Japan Endometriosis Market by Treatment
6.3.4.2.3 Japan Endometriosis Market by Distribution Channel
6.3.4.3 India Endometriosis Market
6.3.4.3.1 India Endometriosis Market by Type
6.3.4.3.2 India Endometriosis Market by Treatment
6.3.4.3.3 India Endometriosis Market by Distribution Channel
6.3.4.4 South Korea Endometriosis Market
6.3.4.4.1 South Korea Endometriosis Market by Type
6.3.4.4.2 South Korea Endometriosis Market by Treatment
6.3.4.4.3 South Korea Endometriosis Market by Distribution Channel
6.3.4.5 Singapore Endometriosis Market
6.3.4.5.1 Singapore Endometriosis Market by Type
6.3.4.5.2 Singapore Endometriosis Market by Treatment
6.3.4.5.3 Singapore Endometriosis Market by Distribution Channel
6.3.4.6 Malaysia Endometriosis Market
6.3.4.6.1 Malaysia Endometriosis Market by Type
6.3.4.6.2 Malaysia Endometriosis Market by Treatment
6.3.4.6.3 Malaysia Endometriosis Market by Distribution Channel
6.3.4.7 Rest of Asia Pacific Endometriosis Market
6.3.4.7.1 Rest of Asia Pacific Endometriosis Market by Type
6.3.4.7.2 Rest of Asia Pacific Endometriosis Market by Treatment
6.3.4.7.3 Rest of Asia Pacific Endometriosis Market by Distribution Channel
6.4 LAMEA Endometriosis Market
6.4.1 LAMEA Endometriosis Market by Type
6.4.1.1 LAMEA Superficial Peritoneal Lesion Market by Country
6.4.1.2 LAMEA Endometriomas Market by Country
6.4.1.3 LAMEA Others Market by Country
6.4.2 LAMEA Endometriosis Market by Treatment
6.4.2.1 LAMEA Oral Contraceptives Market by Country
6.4.2.2 LAMEA Gonadotropin-releasing hormone (GnRH) medicines Market by Country
6.4.2.3 LAMEA Others Market by Country
6.4.3 LAMEA Endometriosis Market by Distribution Channel
6.4.3.1 LAMEA Hospital Pharmacy Market by Country
6.4.3.2 LAMEA Retail Pharmacy Market by Country
6.4.3.3 LAMEA Online Pharmacy Market by Country
6.4.4 LAMEA Endometriosis Market by Country
6.4.4.1 Brazil Endometriosis Market
6.4.4.1.1 Brazil Endometriosis Market by Type
6.4.4.1.2 Brazil Endometriosis Market by Treatment
6.4.4.1.3 Brazil Endometriosis Market by Distribution Channel
6.4.4.2 Argentina Endometriosis Market
6.4.4.2.1 Argentina Endometriosis Market by Type
6.4.4.2.2 Argentina Endometriosis Market by Treatment
6.4.4.2.3 Argentina Endometriosis Market by Distribution Channel
6.4.4.3 UAE Endometriosis Market
6.4.4.3.1 UAE Endometriosis Market by Type
6.4.4.3.2 UAE Endometriosis Market by Treatment
6.4.4.3.3 UAE Endometriosis Market by Distribution Channel
6.4.4.4 Saudi Arabia Endometriosis Market
6.4.4.4.1 Saudi Arabia Endometriosis Market by Type
6.4.4.4.2 Saudi Arabia Endometriosis Market by Treatment
6.4.4.4.3 Saudi Arabia Endometriosis Market by Distribution Channel
6.4.4.5 South Africa Endometriosis Market
6.4.4.5.1 South Africa Endometriosis Market by Type
6.4.4.5.2 South Africa Endometriosis Market by Treatment
6.4.4.5.3 South Africa Endometriosis Market by Distribution Channel
6.4.4.6 Nigeria Endometriosis Market
6.4.4.6.1 Nigeria Endometriosis Market by Type
6.4.4.6.2 Nigeria Endometriosis Market by Treatment
6.4.4.6.3 Nigeria Endometriosis Market by Distribution Channel
6.4.4.7 Rest of LAMEA Endometriosis Market
6.4.4.7.1 Rest of LAMEA Endometriosis Market by Type
6.4.4.7.2 Rest of LAMEA Endometriosis Market by Treatment
6.4.4.7.3 Rest of LAMEA Endometriosis Market by Distribution Channel

Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Teva Pharmaceutical Industries Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Product Launches and Product Expansions:
7.3 Sun Pharmaceutical Industries Ltd.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.4 Sanofi S.A.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 AbbVie, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Trials and Approvals:
7.6 AstraZeneca PLC
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.7 Pfizer, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional & Segmental Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Partnerships, Collaborations, and Agreements:
7.7.5.2 Trials and Approvals:
7.8 Merck & Co., Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expenses
7.8.5 Recent strategies and developments:
7.8.5.1 Trials and Approvals:
7.9 GlaxoSmithKline PLC
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Trials and Approvals:
7.9.5.2 Acquisition and Mergers:
7.10. Consilient Health Limited
7.10.1 Company Overview

TABLE 1 Global Endometriosis Market, 2018 - 2021, USD Million
TABLE 2 Global Endometriosis Market, 2022 - 2028, USD Million
TABLE 3 Global Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 4 Global Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 5 Global Superficial Peritoneal Lesion Market by Region, 2018 - 2021, USD Million
TABLE 6 Global Superficial Peritoneal Lesion Market by Region, 2022 - 2028, USD Million
TABLE 7 Global Endometriomas Market by Region, 2018 - 2021, USD Million
TABLE 8 Global Endometriomas Market by Region, 2022 - 2028, USD Million
TABLE 9 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 10 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 11 Global Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 12 Global Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 13 Global Oral Contraceptives Market by Region, 2018 - 2021, USD Million
TABLE 14 Global Oral Contraceptives Market by Region, 2022 - 2028, USD Million
TABLE 15 Global Gonadotropin-releasing hormone (GnRH) medicines Market by Region, 2018 - 2021, USD Million
TABLE 16 Global Gonadotropin-releasing hormone (GnRH) medicines Market by Region, 2022 - 2028, USD Million
TABLE 17 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 18 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 19 Global Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 20 Global Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 21 Global Hospital Pharmacy Market by Region, 2018 - 2021, USD Million
TABLE 22 Global Hospital Pharmacy Market by Region, 2022 - 2028, USD Million
TABLE 23 Global Retail Pharmacy Market by Region, 2018 - 2021, USD Million
TABLE 24 Global Retail Pharmacy Market by Region, 2022 - 2028, USD Million
TABLE 25 Global Online Pharmacy Market by Region, 2018 - 2021, USD Million
TABLE 26 Global Online Pharmacy Market by Region, 2022 - 2028, USD Million
TABLE 27 Global Endometriosis Market by Region, 2018 - 2021, USD Million
TABLE 28 Global Endometriosis Market by Region, 2022 - 2028, USD Million
TABLE 29 North America Endometriosis Market, 2018 - 2021, USD Million
TABLE 30 North America Endometriosis Market, 2022 - 2028, USD Million
TABLE 31 North America Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 32 North America Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 33 North America Superficial Peritoneal Lesion Market by Country, 2018 - 2021, USD Million
TABLE 34 North America Superficial Peritoneal Lesion Market by Country, 2022 - 2028, USD Million
TABLE 35 North America Endometriomas Market by Country, 2018 - 2021, USD Million
TABLE 36 North America Endometriomas Market by Country, 2022 - 2028, USD Million
TABLE 37 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 38 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 39 North America Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 40 North America Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 41 North America Oral Contraceptives Market by Country, 2018 - 2021, USD Million
TABLE 42 North America Oral Contraceptives Market by Country, 2022 - 2028, USD Million
TABLE 43 North America Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2018 - 2021, USD Million
TABLE 44 North America Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2022 - 2028, USD Million
TABLE 45 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 46 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 47 North America Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 48 North America Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 49 North America Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 50 North America Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 51 North America Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 52 North America Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 53 North America Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 54 North America Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 55 North America Endometriosis Market by Country, 2018 - 2021, USD Million
TABLE 56 North America Endometriosis Market by Country, 2022 - 2028, USD Million
TABLE 57 US Endometriosis Market, 2018 - 2021, USD Million
TABLE 58 US Endometriosis Market, 2022 - 2028, USD Million
TABLE 59 US Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 60 US Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 61 US Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 62 US Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 63 US Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 64 US Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 65 Canada Endometriosis Market, 2018 - 2021, USD Million
TABLE 66 Canada Endometriosis Market, 2022 - 2028, USD Million
TABLE 67 Canada Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 68 Canada Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 69 Canada Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 70 Canada Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 71 Canada Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 72 Canada Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 73 Mexico Endometriosis Market, 2018 - 2021, USD Million
TABLE 74 Mexico Endometriosis Market, 2022 - 2028, USD Million
TABLE 75 Mexico Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 76 Mexico Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 77 Mexico Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 78 Mexico Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 79 Mexico Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 80 Mexico Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 81 Rest of North America Endometriosis Market, 2018 - 2021, USD Million
TABLE 82 Rest of North America Endometriosis Market, 2022 - 2028, USD Million
TABLE 83 Rest of North America Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 84 Rest of North America Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 85 Rest of North America Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 86 Rest of North America Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 87 Rest of North America Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 88 Rest of North America Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 89 Europe Endometriosis Market, 2018 - 2021, USD Million
TABLE 90 Europe Endometriosis Market, 2022 - 2028, USD Million
TABLE 91 Europe Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 92 Europe Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 93 Europe Superficial Peritoneal Lesion Market by Country, 2018 - 2021, USD Million
TABLE 94 Europe Superficial Peritoneal Lesion Market by Country, 2022 - 2028, USD Million
TABLE 95 Europe Endometriomas Market by Country, 2018 - 2021, USD Million
TABLE 96 Europe Endometriomas Market by Country, 2022 - 2028, USD Million
TABLE 97 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 98 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 99 Europe Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 100 Europe Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 101 Europe Oral Contraceptives Market by Country, 2018 - 2021, USD Million
TABLE 102 Europe Oral Contraceptives Market by Country, 2022 - 2028, USD Million
TABLE 103 Europe Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2018 - 2021, USD Million
TABLE 104 Europe Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2022 - 2028, USD Million
TABLE 105 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 106 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 107 Europe Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 108 Europe Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 109 Europe Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 110 Europe Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 111 Europe Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 112 Europe Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 113 Europe Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 114 Europe Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 115 Europe Endometriosis Market by Country, 2018 - 2021, USD Million
TABLE 116 Europe Endometriosis Market by Country, 2022 - 2028, USD Million
TABLE 117 Germany Endometriosis Market, 2018 - 2021, USD Million
TABLE 118 Germany Endometriosis Market, 2022 - 2028, USD Million
TABLE 119 Germany Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 120 Germany Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 121 Germany Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 122 Germany Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 123 Germany Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 124 Germany Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 125 UK Endometriosis Market, 2018 - 2021, USD Million
TABLE 126 UK Endometriosis Market, 2022 - 2028, USD Million
TABLE 127 UK Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 128 UK Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 129 UK Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 130 UK Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 131 UK Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 132 UK Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 133 France Endometriosis Market, 2018 - 2021, USD Million
TABLE 134 France Endometriosis Market, 2022 - 2028, USD Million
TABLE 135 France Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 136 France Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 137 France Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 138 France Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 139 France Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 140 France Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 141 Russia Endometriosis Market, 2018 - 2021, USD Million
TABLE 142 Russia Endometriosis Market, 2022 - 2028, USD Million
TABLE 143 Russia Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 144 Russia Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 145 Russia Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 146 Russia Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 147 Russia Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 148 Russia Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 149 Spain Endometriosis Market, 2018 - 2021, USD Million
TABLE 150 Spain Endometriosis Market, 2022 - 2028, USD Million
TABLE 151 Spain Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 152 Spain Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 153 Spain Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 154 Spain Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 155 Spain Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 156 Spain Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 157 Italy Endometriosis Market, 2018 - 2021, USD Million
TABLE 158 Italy Endometriosis Market, 2022 - 2028, USD Million
TABLE 159 Italy Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 160 Italy Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 161 Italy Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 162 Italy Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 163 Italy Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 164 Italy Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 165 Rest of Europe Endometriosis Market, 2018 - 2021, USD Million
TABLE 166 Rest of Europe Endometriosis Market, 2022 - 2028, USD Million
TABLE 167 Rest of Europe Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 168 Rest of Europe Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 169 Rest of Europe Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 170 Rest of Europe Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 171 Rest of Europe Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 172 Rest of Europe Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 173 Asia Pacific Endometriosis Market, 2018 - 2021, USD Million
TABLE 174 Asia Pacific Endometriosis Market, 2022 - 2028, USD Million
TABLE 175 Asia Pacific Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 176 Asia Pacific Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 177 Asia Pacific Superficial Peritoneal Lesion Market by Country, 2018 - 2021, USD Million
TABLE 178 Asia Pacific Superficial Peritoneal Lesion Market by Country, 2022 - 2028, USD Million
TABLE 179 Asia Pacific Endometriomas Market by Country, 2018 - 2021, USD Million
TABLE 180 Asia Pacific Endometriomas Market by Country, 2022 - 2028, USD Million
TABLE 181 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 182 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 183 Asia Pacific Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 184 Asia Pacific Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 185 Asia Pacific Oral Contraceptives Market by Country, 2018 - 2021, USD Million
TABLE 186 Asia Pacific Oral Contraceptives Market by Country, 2022 - 2028, USD Million
TABLE 187 Asia Pacific Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2018 - 2021, USD Million
TABLE 188 Asia Pacific Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2022 - 2028, USD Million
TABLE 189 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 190 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 191 Asia Pacific Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 192 Asia Pacific Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 193 Asia Pacific Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 194 Asia Pacific Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 195 Asia Pacific Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 196 Asia Pacific Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 197 Asia Pacific Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 198 Asia Pacific Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 199 Asia Pacific Endometriosis Market by Country, 2018 - 2021, USD Million
TABLE 200 Asia Pacific Endometriosis Market by Country, 2022 - 2028, USD Million
TABLE 201 China Endometriosis Market, 2018 - 2021, USD Million
TABLE 202 China Endometriosis Market, 2022 - 2028, USD Million
TABLE 203 China Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 204 China Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 205 China Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 206 China Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 207 China Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 208 China Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 209 Japan Endometriosis Market, 2018 - 2021, USD Million
TABLE 210 Japan Endometriosis Market, 2022 - 2028, USD Million
TABLE 211 Japan Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 212 Japan Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 213 Japan Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 214 Japan Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 215 Japan Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 216 Japan Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 217 India Endometriosis Market, 2018 - 2021, USD Million
TABLE 218 India Endometriosis Market, 2022 - 2028, USD Million
TABLE 219 India Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 220 India Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 221 India Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 222 India Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 223 India Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 224 India Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 225 South Korea Endometriosis Market, 2018 - 2021, USD Million
TABLE 226 South Korea Endometriosis Market, 2022 - 2028, USD Million
TABLE 227 South Korea Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 228 South Korea Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 229 South Korea Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 230 South Korea Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 231 South Korea Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 232 South Korea Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 233 Singapore Endometriosis Market, 2018 - 2021, USD Million
TABLE 234 Singapore Endometriosis Market, 2022 - 2028, USD Million
TABLE 235 Singapore Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 236 Singapore Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 237 Singapore Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 238 Singapore Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 239 Singapore Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 240 Singapore Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 241 Malaysia Endometriosis Market, 2018 - 2021, USD Million
TABLE 242 Malaysia Endometriosis Market, 2022 - 2028, USD Million
TABLE 243 Malaysia Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 244 Malaysia Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 245 Malaysia Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 246 Malaysia Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 247 Malaysia Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 248 Malaysia Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 249 Rest of Asia Pacific Endometriosis Market, 2018 - 2021, USD Million
TABLE 250 Rest of Asia Pacific Endometriosis Market, 2022 - 2028, USD Million
TABLE 251 Rest of Asia Pacific Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 252 Rest of Asia Pacific Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 253 Rest of Asia Pacific Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 254 Rest of Asia Pacific Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 255 Rest of Asia Pacific Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 256 Rest of Asia Pacific Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 257 LAMEA Endometriosis Market, 2018 - 2021, USD Million
TABLE 258 LAMEA Endometriosis Market, 2022 - 2028, USD Million
TABLE 259 LAMEA Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 260 LAMEA Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 261 LAMEA Superficial Peritoneal Lesion Market by Country, 2018 - 2021, USD Million
TABLE 262 LAMEA Superficial Peritoneal Lesion Market by Country, 2022 - 2028, USD Million
TABLE 263 LAMEA Endometriomas Market by Country, 2018 - 2021, USD Million
TABLE 264 LAMEA Endometriomas Market by Country, 2022 - 2028, USD Million
TABLE 265 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 266 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 267 LAMEA Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 268 LAMEA Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 269 LAMEA Oral Contraceptives Market by Country, 2018 - 2021, USD Million
TABLE 270 LAMEA Oral Contraceptives Market by Country, 2022 - 2028, USD Million
TABLE 271 LAMEA Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2018 - 2021, USD Million
TABLE 272 LAMEA Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2022 - 2028, USD Million
TABLE 273 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 274 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 275 LAMEA Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 276 LAMEA Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 277 LAMEA Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 278 LAMEA Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 279 LAMEA Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 280 LAMEA Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 281 LAMEA Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 282 LAMEA Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 283 LAMEA Endometriosis Market by Country, 2018 - 2021, USD Million
TABLE 284 LAMEA Endometriosis Market by Country, 2022 - 2028, USD Million
TABLE 285 Brazil Endometriosis Market, 2018 - 2021, USD Million
TABLE 286 Brazil Endometriosis Market, 2022 - 2028, USD Million
TABLE 287 Brazil Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 288 Brazil Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 289 Brazil Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 290 Brazil Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 291 Brazil Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 292 Brazil Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 293 Argentina Endometriosis Market, 2018 - 2021, USD Million
TABLE 294 Argentina Endometriosis Market, 2022 - 2028, USD Million
TABLE 295 Argentina Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 296 Argentina Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 297 Argentina Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 298 Argentina Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 299 Argentina Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 300 Argentina Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 301 UAE Endometriosis Market, 2018 - 2021, USD Million
TABLE 302 UAE Endometriosis Market, 2022 - 2028, USD Million
TABLE 303 UAE Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 304 UAE Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 305 UAE Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 306 UAE Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 307 UAE Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 308 UAE Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 309 Saudi Arabia Endometriosis Market, 2018 - 2021, USD Million
TABLE 310 Saudi Arabia Endometriosis Market, 2022 - 2028, USD Million
TABLE 311 Saudi Arabia Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 312 Saudi Arabia Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 313 Saudi Arabia Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 314 Saudi Arabia Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 315 Saudi Arabia Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 316 Saudi Arabia Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 317 South Africa Endometriosis Market, 2018 - 2021, USD Million
TABLE 318 South Africa Endometriosis Market, 2022 - 2028, USD Million
TABLE 319 South Africa Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 320 South Africa Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 321 South Africa Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 322 South Africa Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 323 South Africa Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 324 South Africa Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 325 Nigeria Endometriosis Market, 2018 - 2021, USD Million
TABLE 326 Nigeria Endometriosis Market, 2022 - 2028, USD Million
TABLE 327 Nigeria Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 328 Nigeria Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 329 Nigeria Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 330 Nigeria Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 331 Nigeria Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 332 Nigeria Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 333 Rest of LAMEA Endometriosis Market, 2018 - 2021, USD Million
TABLE 334 Rest of LAMEA Endometriosis Market, 2022 - 2028, USD Million
TABLE 335 Rest of LAMEA Endometriosis Market by Type, 2018 - 2021, USD Million
TABLE 336 Rest of LAMEA Endometriosis Market by Type, 2022 - 2028, USD Million
TABLE 337 Rest of LAMEA Endometriosis Market by Treatment, 2018 - 2021, USD Million
TABLE 338 Rest of LAMEA Endometriosis Market by Treatment, 2022 - 2028, USD Million
TABLE 339 Rest of LAMEA Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 340 Rest of LAMEA Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 341 Key Information – Abbott Laboratories
TABLE 342 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 343 Key Information – Sun Pharmaceutical Industries Ltd.
TABLE 344 Key Information – Sanofi S.A.
TABLE 345 Key information – AbbVie, Inc.
TABLE 346 KEY INFORMATION – AstraZeneca PLC
TABLE 347 Key Information – Pfizer, Inc.
TABLE 348 KEY INFORMATION - Merck & Co., Inc.
TABLE 349 Key Information – GlaxoSmithKline PLC
TABLE 350 Key Information – Consilient Health Limited

List of Figures
FIG 1 Methodology for the research
FIG 2 Global Endometriosis Market share by Type, 2021
FIG 3 Global Endometriosis Market share by Type, 2028
FIG 4 Global Endometriosis Market by Type, 2018 - 2028, USD Million
FIG 5 Global Endometriosis Market share by Treatment, 2021
FIG 6 Global Endometriosis Market share by Treatment, 2028
FIG 7 Global Endometriosis Market by Treatment, 2018 - 2028, USD Million
FIG 8 Global Endometriosis Market share by Distribution Channel, 2021
FIG 9 Global Endometriosis Market share by Distribution Channel, 2028
FIG 10 Global Endometriosis Market by Distribution Channel, 2018 - 2028, USD Million
FIG 11 Global Endometriosis Market share by Region, 2021
FIG 12 Global Endometriosis Market share by Region, 2028
FIG 13 Global Endometriosis Market by Region, 2018 - 2028, USD Million
FIG 14 Swot analysis: Abbott laboratories